|Daily Range||$59.61 - $60.45|
|52-Week Range||$45.45 - $71.60|
|Dividend (Yield)||$2.28 (3.8%)|
Dividend Pay Date
|Average Daily Volume||10,858,350|
|Current FY EPS||$4.29|
AbbVie Inc. (ABBV) Description
AbbVie Inc. Website: http://www.abbvie.com/
News & Commentary
Amgen has filed an application for approval of its biosimilar to AbbVie's top-selling Humira.
Gilead Sciences has announced four new regulatory approvals since the start of the quarter, but will they move the company's financials?
A proposed ban on direct-to-consumer prescription drug advertising could spell trouble for the industry's biggest ad spender.
Harvoni still dominates the hepatitis C space, but new competition from Old Pharma is on the way.